Vaxart, Inc.
VXRT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 288.9% | 6,796.3% | -88% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 39% | 100% | -5,365.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -191.2% | -977.5% | -94,000.9% | -7,449.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -233.3% | -1,117.6% | -100,708.4% | -7,900.2% |
| EPS Diluted | -0.14 | -0.17 | -0.22 | -0.14 |
| % Growth | 17.6% | 22.7% | -57.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |